Abeona Therapeutics
ABEO
11 hedge funds and large institutions have $16.1M invested in Abeona Therapeutics in 2014 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$9.64M |
| 2 |
PA
Perceptive Advisors
New York
|
+$4.48M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.55M |
| 4 |
DM
Deerfield Management
New York
|
+$1.34M |
| 5 |
SFM
Soros Fund Management
New York
|
+$897K |
Top Sellers
ABEO Hedge Fund Activity: Q4 2014 in Review
11 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q4 2014, worth a combined $16.1M.
Buyers outnumbered sellers: 11 funds opened new ABEO positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Oracle Investment Management, opening a new position worth an estimated $9.64M.
- 11 institutional investors held Abeona Therapeutics (ABEO) as of Q4 2014, up from 0 in Q3 2014.
- Funds reported $16.1M of Abeona Therapeutics stock for Q4 2014.
- 11 funds opened new Abeona Therapeutics positions in Q4 2014 and 0 closed out, a net change of +11 holders.
- The largest Abeona Therapeutics buyer in Q4 2014 was Oracle Investment Management, an estimated $9.64M added.
Based on aggregated 13F filings for Q4 2014.